Orange Book product · Brand (NDA)

ANJESO

MELOXICAM

Brand (NDA)NDA 210583DISCN BAUDAX

Feb 20, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Feb 20, 2020
6 yr 5 mo ago
Today
Patent 10709713 expires
Listed method-of-use patent (U-2750) expiration.
May 26, 2030
in 4 yr
Patent 11253478 expires
Listed drug product patent expiration.
May 26, 2030
in 4 yr
Patent 9974746 expires
Listed drug product patent expiration.
May 26, 2030
in 4 yr
Patent 10881663 expires
Listed method-of-use patent (U-3038) expiration.
Mar 08, 2039
in 12 yr 11 mo
Patent 11458145 expires
Listed method-of-use patent (U-3318) expiration.
Mar 08, 2039
in 12 yr 11 mo

Active ingredient

MELOXICAM

Strength

30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 210583

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
10709713	May 26, 2030	in 4 yr	U-2750
11253478	May 26, 2030	in 4 yr	ProductU-3318
9974746	May 26, 2030	in 4 yr	Product
10881663	Mar 08, 2039	in 12 yr 11 mo	U-3038
11458145	Mar 08, 2039	in 12 yr 11 mo	U-3318